<DOC>
	<DOCNO>NCT01364350</DOCNO>
	<brief_summary>The purpose study continue follow participant TODAY clinical trial transition non-blinded , non-randomized standard diabetes care management monitor follow-up 24 month ( phase 1 ) , time TODAY data analyze finding interpret develop long-term observational protocol ( phase 2 ) . Data collect phase 1 descriptive purpose ; primary hypothesis .</brief_summary>
	<brief_title>TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study</brief_title>
	<detailed_description>TODAY ( Treatment Options type 2 Diabetes Adolescents Youth ) multi-center study optimal approach treatment type 2 diabetes ( T2D ) child adolescent . The TODAY clinical trial experimental intervention end February 2011 . It follow TODAY2 , longitudinal study continue care observation TODAY cohort beyond end TODAY intervention trial . TODAY2 consist two phase . 1 . First immediate transition TODAY participant non-blinded , non-randomized standard diabetes care management monitor follow-up 24 month . During period , finding TODAY analyze interpret study group . 2 . The second phase protocol long-term longitudinal follow-up TODAY cohort , base finding TODAY . The primary objective first phase TODAY2 continue follow TODAY subject 24 month order begin : - understand persistence effect different treatment regimen use TODAY , - describe continue evolution beta cell function , - describe development vascular complication risk factor complication .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Participated TODAY clinical trial . Provided informed consent participate T2P1 .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>pediatrics</keyword>
	<keyword>post-intervention study</keyword>
	<keyword>metformin</keyword>
	<keyword>complication</keyword>
</DOC>